Navigation Links
Pharmaceutical Pricing and Health Outcomes Top Trending News This Week from HealthEconomics.Com
Date:3/15/2013

Ponte Vedra Beach, FL (PRWEB) March 15, 2013

Top story: The top read story on HealthEconomics.Com was a blog posting on HealthEconomics.Com’s blog, tHEORetically Speaking, by Debra Gordon, MS, entitled “Pricing Cars Like Healthcare”. Medical procedures and therapeutic interventions provided by hospitals have vastly different price points, even for those patients who desire to pay out-of-pocket, and it is exceedingly hard to determine a price at all. Ms. Gordon compares this lack of price transparency within the healthcare sector with the ease of price comparison for common consumer goods, like automobiles or car-related parts. The issues associated with health policy and pricing are debated each week on the tHEORetically Speaking blog.

Another story in HealthEconomics.Com focused on the dilemma among the pharmaceutical industry C-Suite executives who believe that the constantly evolving business model among major payers and managed markets is a “pain point”, according to research by Cegedim discussed in a Medical Marketing & Media Leadership Exchange. The silo approach currently used by pharma to address payer issues results in separation between marketing, sales, and managed markets departments. This results in a lack of understanding, inconsistency of message, market access challenges, and resource waste. This organizational breakdown is also evident in the lack of a focused digital strategy by pharma for the payer audience. HealthEconomics.Com covered this important story, and provides in-depth strategies and tactics to the pharmaceutical industry to converse with the payer audience using a variety of digital means. (Original story sourced from Medical Marketing & Media Leadership Exchange: Pact With the Payer, Oct. 2012).

Another trending story on HealthEconomics.Com was by research analyst Sarah Ray, who blogged about International Reference Pricing and compared it to sibling rivalry. International price referencing relates to how countries around the world set the price (or, more commonly, the reimbursable price) of a drug product by evaluating the price of that product in various countries in their geographical region. Ms. Ray notes that this process is akin to siblings in their never-ending quests to ensure equality amongst themselves. The pharmaceutical industry is well-versed in the international pricing game, and uses a global launch sequence to determine the order in which they launch products around the world, maximizing their price points. A recent survey by Cutting Edge Information found that price referencing was the top consideration for 67% of surveyed companies, and of utmost importance to pharma executives.

About HealthEconomics.Com (http://www.healtheconomics.com): A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and pharma market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.

Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/TopNews/prweb10532217.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
2. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
3. Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
4. ISPE Conference to Benchmark and Advance Quality by Design in the Biopharmaceutical Industry
5. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
6. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
7. AVANIR Pharmaceuticals To participate in two conferences in March
8. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
9. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
10. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
11. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... platform specifically designed for life science researchers to analyze and interpret datasets, ... Franklin, who made a major contribution to the discovery of the double-helix ...
(Date:10/11/2017)... Palo Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... is set to take place on 7th and 8th June 2018 in San Francisco, ... and policy influencers as well as several distinguished CEOs, board directors and government officials ...
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):